• 1
    Habib R, Zurowska A, Hinglais N et al. A specific glomerular lesion of the graft: Allograft glomerulopathy. Kidney Int 1993; 44(Suppl): S104S111.
  • 2
    Habib R, Broyer M. Clinical significance of allograft glomerulopathy. Kidney Int 1993; 43(Suppl): S95S98.
  • 3
    Racusen LC, Solez K, Colvin RB, Bonsib SM, Castro MC, Cavallo T. The Banff 97 working classification for renal allograft pathology. Kidney Int 1999; 55: 713723.
  • 4
    Gloor JM, Cosio FG, Rea DJ et al. Histologic findings one year after positive crossmatch or ABO blood group incompatible living donor kidney transplantation. Am J Transplant 2006; 6: 1841–1847.
  • 5
    Vongwiwatana A, Gourishankar S, Campbell PM, Solez K, Halloran PF. Peritubular capillary changes and C4 d deposits are associated with transplant glomerulopathy but not IgA nephropathy. Am J Transplant 2004; 4: 124129.
  • 6
    Suri DL, Tomlanovich SJ, Olson JL, Meyer TW. Transplant glomerulopathy as a cause of late graft loss. Am J Kid Dis 2000; 35.
  • 7
    Cosio FG, Grande JP, Larson TS et al. Kidney allograft fibrosis and atrophy early after living donor transplantation. Am J Transplant 2005; 5: 17.
  • 8
    Cosio FG, Grande JP, Wadei H, Larson TS, Griffin MD, Stegall MD. Predicting subsequent decline in kidney allograft function from early surveillance biopsies. Am J Transplant 2005; 5: 24642472.
  • 9
    Racusen LC, Colvin RB, Solez K et al. Antibody-mediated rejection criteria- an addition to the Banff ‘97 classification of renal allograft rejection. Am J Transplant 2003; 3: 708714.
  • 10
    Wilson DM, Bergert JH, Larson TS, Liedtke RR. GFR determined by nonradiolabeled iothalamate using capillary electrophoresis. Am J Kid Dis 1997; 30: 646652.
  • 11
    Levey AS, Greene T, Schluchter MD. Glomerular filtration rate measurements in clinical trials. Modification of Diet in Renal Disease Study Group and the Diabetes Control and Complications Trial Research Group. J Am Soc Nephrol 1993; 4: 11591171.
  • 12
    Gloor JM, DeGoey S, Ploeger N et al. Persistence of low levels of alloantibody after desensitization in crossmatch positive living donor kidney transplantation. Transplantation 2003; 78: 221227.
  • 13
    Banfi G, Villa M, Cresseri D, Ponticelli C. The clinical impact of chronic transplant glomerulopathy in cyclosporine era. Transplantation 2005; 80: 13921397.
  • 14
    Horita S, Nitta K, Kawashima M et al. C4 d deposition in the glomeruli and peritubular capillaries associated with transplant glomerulpathy. Clin Transplan 2003; 17: 325330.
  • 15
    Maryniak RK, First MR, Weiss MA. Transplant glomerulopathy: Evolution of morphologically distinct changes. Kidney Int 1985; 27: 799806.
  • 16
    Evans PR, Trickett LP, Smith JL, MacIver AG, Tate D, Slapak M. Varying expression of major histocompatibility complex antigens on human renal endothelium and epithelium. Br J Exp Pathol 1985; 66: 7987.
  • 17
    Muczynski KA, Cotner T, Anderson SK. Unusual expression of human lymphocyte antigen class II in normal renal microvascular endothelium. Kid International 2001; 59: 488497.
  • 18
    Muczynski KA, Ekle DM, Coder DM, Anderson SK. Normal human kidney HLA-DR-expressing renal microvascular endothelial cells: Characterization, isolation, and regulation of MHC class II expression. J Am Soc Nephrol 2003; 14: 13361348.
  • 19
    Cosio FG, Sedmak DD, Henry ML et al. The high prevalence of severe early posttransplant renal allograft pathology in hepatitis C positive recipients. Transplantation 1996; 62: 10541059.
  • 20
    Regele H, Bohmig GA, Habich A et al. Capillary deposition of complement split product C4 d in renal allografts is associated with basement membrane injury in peritubular and glomerular capillaries: A contribution of humoral immunity to chronic allograft rejection. J Am Soc Nephrol 2002; 13: 23712380.
  • 21
    Slipkens YW, Joosten SA, Wong M-C et al. Immunologic risk factors and glomerular C4 d depositis in chronic transplant glomerulopathy. Kidney Int 2004; 65: 24092418.
  • 22
    Plissonier D, Henaff M, Poncet P et al. Involvement of antibody-dependent apoptosis in graft rejection. Transplantation 2000; 69: 26012608.
  • 23
    Smith RN, Kawai T, Boskovic S et al. Chronic antibody mediated rejection of renal allografts: Pathological, serological, and immunologic features in nonhuman primates. Am J Transplant 2006; 6: 17901798.
  • 24
    Gough J, Yilmaz A, Miskulin D et al. Peritubular capillary basement membrane reduplication in allografts and native kidney disease. Transplantation 2001; 71: 13901393.
  • 25
    Lajoie G. Antibody-mediated rejection of human renal allografts: An electron microscopic study of peritubular capillaries. Ultrastruct Pathol 1997; 21: 235242.